Lawrence M. Sung

Partner

Dr. Sung is a registered patent attorney with a Ph.D. in microbiology and has 18 years of experience in biotechnology, medical device and pharmaceutical patent counseling, litigation and technology transfer. A former judicial clerk to (now Senior) Circuit Judge Raymond C. Clevenger, III, of the U.S. Court of Appeals for the Federal Circuit, Dr. Sung has also been involved extensively in patent appeals.

In addition, Dr. Sung holds the appointment of law school professor and director of the Intellectual Property Law Program at the University of Maryland School of Law. He has also taught at the Northwestern School of Law of Lewis & Clark College, George Washington University Law School, American University, Washington College of Law and the Seattle University School of Law. Dr. Sung has served as a consultant to the National Human Genome Research Institute and as a member of the National Academies Standing Committee on Emerging Issues and Data on Environmental Contaminants. He is a prolific speaker and author, and his books include Patent Law Handbook, Patent Infringement Remedies and Medical Device Patents.

Recent Representations

  • Lead Counsel, McQueen v. Woodstream Corp., No. 10-7002 (D.C. Cir. 2010).
  • Lead Counsel, McQueen v. Woodstream Corp., No. 1:05-cv-02068-RMU (D.D.C. 2010).
  • Lead Counsel, Brief of Amicus Curiae Medtronic, Inc. in Support of Neither Party, Bilski v. Kappos, No. 08-964 (U.S. 2009).

Bar Associations, Memberships and Activities

  • American Bar Association
  • American Intellectual Property Law Association
  • American Association for the Advancement of Science
  • American Society for Microbiology

Board Memberships

  • Past Chair, Asian-Pacific American Bar Association of the District of Columbia Partners’ Forum
  • Past Chair, The National Research Council Committee on Intellectual Property Concerns for Toxicogenomics

Publications

  • Author, Contemporary Debates In Bioethics, Part Five: Is it ethical to patent or copyright genes, embryos, or their parts? (in press) (book chapter).
  • Co-Author with Jeff E. Schwartz, 2011-2012 Patent Law Handbook, Thomson/West (in press) (book).
  • Author, 2010 Supplement to Patent Infringement Remedies, BNA Books (in press) (book). 
  • Author, Medical Alert: Alarming Challenges Facing Medical Technology Innovation, 6 J. Bus. & Tech. L. 35 (2011) (law review article).
  • Author, 2010 Medical Device Patents, Thomson/West (book).

Speeches and Programs

  • Invited Chair & Speaker, Informex Biologics 2011, Forewarned is forearmed: Preparing an effective 351(k) biosimilars patent strategy (Boston, MA, NY Oct. 4-6, 2011).
  • Invited Speaker, American Conference Institute, Life Sciences Business Development & Acquisitions, Demystifying the Unique Legal and Regulatory Challenges in Entering into Early Stage Research Partnerships in Emerging Markets (New York, NY Sep. 27, 2011).
  • Invited Speaker, American Intellectual Property Law Association, Practical Patent Prosecution for New Lawyers – Biotechnology Claim Drafting (Alexandria, VA, Aug. 23, 2011).
  • Invited Speaker, LexisNexis and Managing IP Event: Gene Patenting in the Wake of Myriad Genetics (Washington, DC, Aug. 10, 2011).
  • Speaker, Dewey & LeBoeuf Life Sciences Webinar, Predicting the Future of Biosimilars, FDA and IP Aspects (Washington, DC, Jul. 21, 2011).
  • Speaker, Asia Pacific Legal Institute, 2011 Summer Intellectual Property Training Program, Biotechnology Patent Protection (Washington, DC, Jul. 13, 2011).
  • Speaker, Licensing Executive Society 2011 Spring Meeting, Trends in Biosimilars and Implications for Licensing (New York, NY, May 6, 2011).
  • Speaker, Frontiers in Stem Cells and Cancer Research, Intellectual Property Concerns (Washington, DC, Mar. 18, 2011).
  • Speaker, Dewey & LeBoeuf Life Sciences Event, Ensuring Your Patent Claims Will Capture Joint Infringers (New York, NY, Mar. 3, 2011).
  • Speaker, VisionGain Biosimilars & Follow on Biologics Americas Conference, The Threat of Intellectual Property Strategies (Boston, MA, Mar. 2, 2011).
  • Speaker, LexisNexis and Managing IP Webinar: False Marking (Washington, DC, Dec. 18, 2010).
  • Speaker, Dewey & LeBoeuf Life Sciences Event, Patent Eligibility Concerns for Medical Diagnostic Methods & False Marking Liability Risks (New York, NY, Nov. 17, 2010).
  • Speaker, 2010 Stem Cell USA & Regenerative Medicine Congress – Intellectual property hurdles in the future of iPS cell research (Philadelphia, PA, Sept. 14, 2010).

Education

  • American University, Washington College of Law, 1993, J.D., cum laude
  • University of Pennsylvania, 1985, B.A.
  • United States Department of Defense Uniformed Services University, 1990, Ph.D.

Bar Admissions

  • Pennsylvania
  • District of Columbia

Court Admissions

  • U.S. Patent and Trademark Office
  • U.S. Supreme Court
  • U.S. Court of Appeals, Federal Circuit
  • U.S. Court of Appeals, District of Columbia Circuit
  • U.S. District Court, District of Columbia